Patent assignee · FR · COMPANY

HOSPICES CIVILS DE LYON

🏢 View company profile →
45Patents
44Active
45Granted
54Portfolio score

Filing activity: Dec 4, 2002 → Apr 25, 2023 · 5 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7414024B2 Proteins with IL-6 inhibiting activity Human Necessities 21 Expired
US8419426B2 Device for positioning and immobilizing a surgical guide in a patient's mouth Human Necessities 8 Active
US9433592B2 Pharmaceutical or veterinary antiviral compositions Human Necessities 4 Active
US9120856B2 Anti-CD19 antibody having ADCC function with improved glycosylation profile Chemistry; Metallurgy 3 Active
US9381238B2 Method for improving the production of influenza viruses and vaccine seeds Chemistry; Metallurgy 3 Active
US9823239B2 Process for determining the susceptibility to nosocomial infections Physics 2 Active
US9247720B2 Primate model from the family cercopithecidae infected by a HBV strain of human genotype Chemistry; Metallurgy 2 Active
US10007985B2 Method for the automatic segmentation and quantification of body tissues Physics 2 Active
US11351180B2 Antiviral compositions for treating the flu Human Necessities 1 Active
US10533046B2 Anti-CK8 antibodies for use in the treatment of colorectal cancers Physics 1 Active
US8956626B2 Modified viral strains and method for improving the production of vaccine seeds of influenza virus Chemistry; Metallurgy 1 Active
US10144917B2 Method for preparing a vaccine antigen, resulting vaccine antigen and uses Chemistry; Metallurgy 1 Active
US10624976B2 Dendronized metallic oxide nanoparticles, a process for preparing the same and their uses Chemistry; Metallurgy 1 Active
US10168327B2 Protein chips, preparation and use thereof Physics 1 Active
US8778341B2 Anti-CK8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes Human Necessities 1 Active
US10725029B2 Kit for in vitro or ex vivo measurement of SCD127 expression in a biological sample Physics 0 Active
US9382571B2 Method for detecting delta haemolysin of Staphylococcus aureus by mass spectrometry directly using a bacterial population Electricity 0 Active
US10663472B2 Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis Physics 0 Active
US11630101B2 Method for diagnosing anomalies in the coagulation of blood Physics 0 Active
US11339438B2 Method for assessing the risk of complications in patients with systemic inflammatory response syndrome (sirs) Chemistry; Metallurgy 0 Active
US11079391B2 Biological marker for evaluating the IL-17 pro-inflammatory functional contribution dependent level in an individual Physics 0 Active
US11377690B2 Method and kit for making an in vitro prognosis of severity for a patient in septic shock Physics 0 Active
US9110079B2 Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS Physics 0 Active
US8623824B2 VIII factors for the treatment of type A hemophilia Human Necessities 0 Active
US9683986B2 Treatment of cancer by inhibition of the MYD88/ERK MAP kinase interaction Physics 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.